Company Profile (AI Text)
Name: Achieve Clinics, Inc.
Canonical URL: https://wefunder.com/achieve.clinics.inc
Updated at: 2026-06-25T05:02:21Z

Tagline: Free-to-patient immune cell banking to supercharge cancer cell therapy access and innovation 

Key claims:
- Total raised on Wefunder: 53518 | citation: https://wefunder.com/achieve.clinics.inc#claim-total-raised
- Total investors: 7 | citation: https://wefunder.com/achieve.clinics.inc#claim-total-investors

Verified facts:
- Total raised on Wefunder: 53518 | observed_at: 2026-06-25T05:02:21Z | expires_at: 2026-06-26T05:02:21Z
- Total investors: 7 | observed_at: 2026-06-25T05:02:21Z | expires_at: 2026-06-26T05:02:21Z

Computed metrics:
- total_amount_raised: 53518
- total_investors: 7
- team_size: 2
- featured_investor_count: 2
- faq_count: 1
- recent_post_count: 0

Quick facts:
- We proactively bank cancer patient immune cells for cell therapy (incl. pre-chemo) at no cost | citation: https://wefunder.com/achieve.clinics.inc#claim-fact-1
- With us, industry can now pre-enroll patients for studies and manufacture with "off-the-shelf" cells | citation: https://wefunder.com/achieve.clinics.inc#claim-fact-2
- Our unique platform generates invaluable large-format, patient records-linked research biomaterial | citation: https://wefunder.com/achieve.clinics.inc#claim-fact-3
- Free-to-patient model fueled by PRO-Aph specimen sales: LOIs reflect ~$0.3m+/pt in potential demand | citation: https://wefunder.com/achieve.clinics.inc#claim-fact-4
- Launch network incl. leaders from Genentech, Penn, Be The Match, xCures, +dozens in active pipeline | citation: https://wefunder.com/achieve.clinics.inc#claim-fact-5
- Initial oncologist support and collection (apheresis) sites expected in Seattle and Houston | citation: https://wefunder.com/achieve.clinics.inc#claim-fact-6
- Proudly endorsed by the Emily Whitehead Foundation (https://emilywhiteheadfoundation.org/) | citation: https://wefunder.com/achieve.clinics.inc#claim-fact-7

FAQ:
- Q: Hi there, a) What is your most recent monthly burn rate? b) What is your most recent monthly cash on hand? c) Are you raising a parallel angel or VC round simultaneously? If yes, who is investing in this round?
  A: Hi Teddy, Thanks for your questions. a) Excluding one-off items like conferences, our monthly burn is minimal at approximately $100. Once cell collection and processing activities begin, we expect those to incur expenses in the single-digit thousands or more per patient. b) Our cash on hand remains materially similar to the last reported balance of $883 c) We remain engaged with angels and VCs, but the only raise terms discussed currently are what you see here. As proud and excited as we are ...